M

MYELOMA PATIENTS EUROPE (International non-profit association)

BE 0842.182.407 Active ●Avenue Louise 143, 1050 Bruxelles

MYELOMA PATIENTS EUROPE is a Belgian company registered with the Crossroads Bank for Enterprises under enterprise number 0842.182.407. It was founded on 28-12-2011. Its registered office is in Brussels. Its main activity is: Activities of membership organisations. Its annual accounts for 2025 report equity of € 1 076 767 and a profit of € 154 630. These accounts report 13.4 full-time equivalents. Addrly gives it a financial health grade of A, on a scale from A (safest) to E (most at risk). It filed its annual accounts within the legal deadline for 3 of its last 4 financial years.

Information last updated on 07-10-2026.

Company information

Status
Active
Enterprise number
BE 0842.182.407
VAT registered
Yes
Founded
28-12-2011
Latest accounts
2025
Employees
13.4 FTE
Region
Brussels-Capital
Establishments
1
Filing record
On time 3 of 4 years
Peppol e-invoicing
Registered
Registered office
Avenue Louise 143, 1050 Bruxelles
Main activity
Activities of membership organisations
NACE activities
94999 Autres associations nca
70200 Activités de conseil pour les affaires et autre conseil de gestion

Key figures of MYELOMA PATIENTS EUROPE

2025202420232022
Profit / loss
iWhat the period earned after taxes. A negative amount is a loss.
€ 154 630+211 %€ 49 725+49 %€ 33 450€ -46 566
Equity
iWhat belongs to the shareholders: capital contributed, reserves and profits kept in the company.
€ 1 076 767+17 %€ 922 137+6 %€ 872 413+4 %€ 838 963
Total assets
iEverything the company owns. Equal to total equity and liabilities, which says how it is financed.
€ 1 728 732-1 %€ 1 746 111+23 %€ 1 418 652+63 %€ 872 114
Gross margin
iSales and other operating income, minus purchases of goods and services. What is left to pay the staff and everything else.
€ 975 752+27 %€ 769 173+8 %€ 709 128+26 %€ 561 695
Employees (FTE)
iAverage number of workers over the period, in full-time equivalents.
13.4+16 %11.6+5 %11+5 %10.5

Financial estimate

Financial health grade A, on a scale from A (safest) to E (most at risk)
Health barometer
The failure probability and the indicators behind this grade are visible with a free account.
Create a free account
Illustrative preview
Detected events
Appointments, capital, registered office, proceedings, extracted from the official acts.
Create a free account
Illustrative preview
Directors & mandates
24 mandates on record in the annual accounts. 3 of them started since 2024.
Create a free account

Similar companies

Other companies in the same activity in Brussels.

CompanyTown
ARCHIPEL 1050 Ixelles
BRANCART CONSULT 1050 Ixelles
DANISH AGRICULTURAL COUNCIL, BRUSSELS 1050 Ixelles
JEUNES MUTUALISTES LIBERAUX 1050 Ixelles
ENHESA 1050 Ixelles
EUROCOMMENT 1050 Ixelles
B19 1050 Ixelles
DOUBLE D EUROPE 1050 Bruxelles
Looking for more information about MYELOMA PATIENTS EUROPE?
The free plan gives you 20 complete company dossiers every month, no card required: health barometer, directors, company links and detected events.
Create a free account

Frequently asked questions

Is MYELOMA PATIENTS EUROPE still active? Yes. The Crossroads Bank for Enterprises lists MYELOMA PATIENTS EUROPE as active.

What is the VAT number of MYELOMA PATIENTS EUROPE? The VAT number of MYELOMA PATIENTS EUROPE is BE 0842.182.407.

When was MYELOMA PATIENTS EUROPE founded? MYELOMA PATIENTS EUROPE was founded on 28-12-2011.

What is the address of MYELOMA PATIENTS EUROPE? The current registered office of MYELOMA PATIENTS EUROPE is Avenue Louise 143, 1050 Bruxelles.

When did MYELOMA PATIENTS EUROPE last file annual accounts? The latest annual accounts of MYELOMA PATIENTS EUROPE were filed on 08-05-2026.

Does MYELOMA PATIENTS EUROPE file its annual accounts on time? MYELOMA PATIENTS EUROPE filed its annual accounts within the legal deadline for 3 of its last 4 financial years. Late: 2022.

How many employees does MYELOMA PATIENTS EUROPE have? MYELOMA PATIENTS EUROPE employs 13.4 full-time equivalents according to its most recent annual accounts.

Is MYELOMA PATIENTS EUROPE financially healthy? Addrly gives MYELOMA PATIENTS EUROPE a financial health grade of A, on a scale from A (safest) to E (most at risk). The failure probability and the indicators behind it are visible with a free account.

Is MYELOMA PATIENTS EUROPE profitable? The annual accounts of MYELOMA PATIENTS EUROPE for 2025 show a profit of € 154 630.

What is the equity of MYELOMA PATIENTS EUROPE? The equity of MYELOMA PATIENTS EUROPE was € 1 076 767 at the close of the 2025 financial year.

Who are the directors of MYELOMA PATIENTS EUROPE? The annual accounts of MYELOMA PATIENTS EUROPE record 24 mandates. The names, roles and dates are visible with a free account.

Can MYELOMA PATIENTS EUROPE receive Peppol e-invoices? Yes. MYELOMA PATIENTS EUROPE is registered on the Peppol network and can receive structured electronic invoices.

What does MYELOMA PATIENTS EUROPE do? The main activity of MYELOMA PATIENTS EUROPE is: Activities of membership organisations.

Sources

How Addrly builds and refreshes this data